Glycan-based Conjugation
Glycan-Based Conjugation is a site-specific antibody conjugation method that exploits the conserved N-glycan structures within the Fc region of immunoglobulins as chemical handles for the attachment of payloads, thereby enabling controlled modification without direct interference with the antigen-binding domains.
182
Publications
8.9K
Citations
991
Authors
267
Institutions
Publications per year
2017–2026
54
Parents
182
A novel glyco-conjugate vaccine against fungal pathogens
Antonella Torosantucci, Carla Bromuro, Paola Chiani et al. · The Journal of Experimental Medicine · 2005 · 443 citations · Full text
Site-Specific Antibody–Drug Conjugation through Glycoengineering
Qun Zhou, James E. Stefano, Charlene Manning et al. · Bioconjugate Chemistry · 2014 · 218 citations
Pharmacy, Oncology, Pharmaceutics +17
1–5 of 182
991
8
h-index
7
h-index
7
h-index
6
h-index
5
h-index
1–5 of 991
267
Toscana Life Sciences
Siena, Italy
9 h-index
68 publications
2.9K citations

Centre National de la Recherche Scientifique
Paris, France
8 h-index
31 publications
915 citations
National Institutes of Health
Bethesda, United States
7 h-index
27 publications
1.6K citations
University of Maryland, College Park
College Park, United States
7 h-index
39 publications
1.3K citations
Center for Cancer Research
Bethesda, United States
6 h-index
27 publications
1.6K citations
Novartis (Italy)
Milan, Italy
6 h-index
60 publications
4K citations
National Cancer Institute
Bethesda, United States
6 h-index
14 publications
864 citations
University of Oxford
Oxford, United Kingdom
6 h-index
20 publications
1.3K citations
1–8 of 267
26 publications · 1.1K citations
18
h-index
9 publications · 421 citations
9
h-index
7 publications · 638 citations
7
h-index
Repository · 7 publications · 337 citations
7
h-index
JACS · 6 publications · 559 citations
6
h-index
1–5